Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.

about

Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells.Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.

P2860

Q46327293-8F4248B8-4F2A-462E-99D6-B00300133BC5 Q52679106-FF7D18F8-D309-4D8D-BDDA-86A7E9277C6B

P2860

Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.

Item

http://www.wikidata.org/entity/Q38739235

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fisetin Enhances Chemotherapeu ...... t Human Prostate Cancer Cells.

@en

type

Item

label

Fisetin Enhances Chemotherapeu ...... t Human Prostate Cancer Cells.

@en

prefLabel

Fisetin Enhances Chemotherapeu ...... t Human Prostate Cancer Cells.

@en

P1476

Fisetin Enhances Chemotherapeu ...... t Human Prostate Cancer Cells.

@en

P2093

Ajit Kumar Verma

http://www.w3.org/2001/XMLSchema#string

Eiman Mukhtar

http://www.w3.org/2001/XMLSchema#string

Hasan Mukhtar

http://www.w3.org/2001/XMLSchema#string

Imtiaz Ahmad Siddiqui

http://www.w3.org/2001/XMLSchema#string

Vaqar Mustafa Adhami

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents

Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management

Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model

Cancer statistics, 2016

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.

A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer.

P304

2863-2874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-16-0515

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27765854

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

5136329

http://www.w3.org/2001/XMLSchema#string

Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.

about

P2860

P2860

Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932